Fungal lung disease.

Area of Science:

• Pulmonology
• Mycology
• Infectious Diseases

Background:

• Fungal lung diseases represent a significant global health burden.
• Disease presentation varies based on host immunity and fungal strain, with Aspergillus species being most common.
• Epidemiology is influenced by geography, environment, and host comorbidities.

Purpose of the Study:

• To review the current landscape of fungal lung disease.
• To highlight key clinical insights, diagnostic challenges, and emerging treatment approaches.
• To discuss the impact of drug resistance and potential future strategies.

Main Methods:

• This is a state-of-the-art review.
• It synthesizes current knowledge on fungal lung disease diagnosis and treatment.
• It examines evolving diagnostic modalities and therapeutic strategies.

Main Results:

• Diagnosis remains challenging, particularly in resource-limited settings, with difficulties in rapid and accurate identification.
• Antifungal drug resistance is a growing global threat, complicating treatment.
• Emerging antifungal agents and understanding the lung mycobiome offer potential for personalized medicine.

Conclusions:

• Accurate and timely diagnosis of fungal lung diseases is critical.
• Combating antifungal drug resistance requires innovative methodologies.
• Future approaches may involve personalized medicine informed by the lung mycobiome.